Literature DB >> 22381368

A continuous fluorescent enzyme assay for early steps of lipid A biosynthesis.

Ronald J Jenkins1, Garry D Dotson.   

Abstract

UDP-N-acetylglucosamine acyltransferase (LpxA) and UDP-3-O-(R-3-hydroxyacyl)-glucosamine acyltransferase (LpxD) catalyze the first and third steps of lipid A biosynthesis, respectively. Both enzymes have been found to be essential for survival among gram-negative bacteria that synthesize lipopolysaccharide and are viable targets for antimicrobial development. Catalytically, both acyltransferases catalyze an acyl-acyl carrier protein (ACP)-dependent transfer of a fatty acyl moiety to a UDP-glucosamine core ring. Here, we exploited the single free thiol unveiled on holo-ACP after transfer of the fatty acyl group to the glucosamine ring using the thiol-specific labeling reagent, ThioGlo. The assay was continuously monitored as a change in fluorescence at λ(ex)=379 nm and λ(em)=513 nm using a microtiter plate reader. This assay marks the first continuous and nonradioactive assay for either acyltransferase.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381368      PMCID: PMC3338867          DOI: 10.1016/j.ab.2012.02.027

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  35 in total

Review 1.  Lipid A: target for antibacterial drugs.

Authors:  M Vaara
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

2.  Antibacterial agents that inhibit lipid A biosynthesis.

Authors:  H R Onishi; B A Pelak; L S Gerckens; L L Silver; F M Kahan; M H Chen; A A Patchett; S M Galloway; S A Hyland; M S Anderson; C R Raetz
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

3.  A left-handed parallel beta helix in the structure of UDP-N-acetylglucosamine acyltransferase.

Authors:  C R Raetz; S L Roderick
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

4.  Comparison of the phenotypes of the lpxA and lpxD mutants of Escherichia coli.

Authors:  R Vuorio; M Vaara
Journal:  FEMS Microbiol Lett       Date:  1995-12-15       Impact factor: 2.742

5.  The envA permeability/cell division gene of Escherichia coli encodes the second enzyme of lipid A biosynthesis. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase.

Authors:  K Young; L L Silver; D Bramhill; P Cameron; S S Eveland; C R Raetz; S A Hyland; M S Anderson
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

6.  A mutant of Escherichia coli defective in the first step of endotoxin biosynthesis.

Authors:  S M Galloway; C R Raetz
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

7.  The novel hexapeptide motif found in the acyltransferases LpxA and LpxD of lipid A biosynthesis is conserved in various bacteria.

Authors:  R Vuorio; T Härkönen; M Tolvanen; M Vaara
Journal:  FEBS Lett       Date:  1994-01-17       Impact factor: 4.124

8.  The firA gene of Escherichia coli encodes UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine N-acyltransferase. The third step of endotoxin biosynthesis.

Authors:  T M Kelly; S A Stachula; C R Raetz; M S Anderson
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

9.  Biosynthesis of lipid A precursors in Escherichia coli. A cytoplasmic acyltransferase that converts UDP-N-acetylglucosamine to UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine.

Authors:  M S Anderson; C R Raetz
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

10.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

View more
  7 in total

1.  Dual targeting antibacterial peptide inhibitor of early lipid A biosynthesis.

Authors:  Ronald J Jenkins; Garry D Dotson
Journal:  ACS Chem Biol       Date:  2012-04-27       Impact factor: 5.100

2.  Structural basis for the recognition of peptide RJPXD33 by acyltransferases in lipid A biosynthesis.

Authors:  Ronald J Jenkins; Kyle A Heslip; Jennifer L Meagher; Jeanne A Stuckey; Garry D Dotson
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

3.  Extragenic suppressor mutations in ΔripA disrupt stability and function of LpxA.

Authors:  Cheryl N Miller; Shaun P Steele; Jason C Brunton; Ronald J Jenkins; Eric D LoVullo; Sharon A Taft-Benz; Artur Romanchuk; Corbin D Jones; Garry D Dotson; Edward J Collins; Thomas H Kawula
Journal:  BMC Microbiol       Date:  2014-12-31       Impact factor: 3.605

4.  PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.

Authors:  Jayme L Dahlin; J Willem M Nissink; Jessica M Strasser; Subhashree Francis; LeeAnn Higgins; Hui Zhou; Zhiguo Zhang; Michael A Walters
Journal:  J Med Chem       Date:  2015-02-21       Impact factor: 8.039

Review 5.  Lipid A as a Drug Target and Therapeutic Molecule.

Authors:  Sang Hoon Joo
Journal:  Biomol Ther (Seoul)       Date:  2015-11-01       Impact factor: 4.634

6.  New virulence factor CSK29544_02616 as LpxA binding partner in Cronobacter sakazakii.

Authors:  Seongok Kim; Hyunjin Yoon; Sangryeol Ryu
Journal:  Sci Rep       Date:  2018-01-16       Impact factor: 4.379

7.  Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation.

Authors:  Paul A Beare; Brendan M Jeffrey; Carrie M Long; Craig M Martens; Robert A Heinzen
Journal:  PLoS Pathog       Date:  2018-02-26       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.